BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31022428)

  • 1. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
    Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
    Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia.
    Carlson KM; Vignon C; Bohlander S; Martinez-Climent JA; Le Beau MM; Rowley JD
    Leukemia; 2000 Jan; 14(1):100-4. PubMed ID: 10637483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
    Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
    Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
    Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
    Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts.
    Narita M; Shimizu K; Hayashi Y; Taki T; Taniwaki M; Hosoda F; Kobayashi H; Nakamura H; Sadamori N; Ohnishi H; Bessho F; Yanagisawa M; Ohki M
    Br J Haematol; 1999 Jun; 105(4):928-37. PubMed ID: 10554802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
    Ohtaka M; Itoh M; Tohda S
    Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
    Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
    Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
    Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
    Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.
    Silliman CC; McGavran L; Wei Q; Miller LA; Li S; Hunger SP
    Leukemia; 1998 Sep; 12(9):1404-10. PubMed ID: 9737689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
    Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
    Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
    Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
    Archangelo LF; Gläsner J; Krause A; Bohlander SK
    Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
    Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
    Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CALM-AF10 gene fusion in acute leukemia.
    Caudell D; Aplan PD
    Leukemia; 2008 Apr; 22(4):678-85. PubMed ID: 18094714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
    Conway AE; Scotland PB; Lavau CP; Wechsler DS
    Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
    Dreyling MH; Schrader K; Fonatsch C; Schlegelberger B; Haase D; Schoch C; Ludwig W; Löffler H; Büchner T; Wörmann B; Hiddemann W; Bohlander SK
    Blood; 1998 Jun; 91(12):4662-7. PubMed ID: 9616163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of iron depletion on CALM-AF10 leukemias.
    Heath JL; Weiss JM; Lavau CP; Wechsler DS
    Exp Hematol; 2014 Dec; 42(12):1022-1030.e1. PubMed ID: 25193880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia.
    La Starza R; Crescenzi B; Krause A; Pierini V; Specchia G; Bardi A; Nieddu R; Ariola C; Nanni M; Diverio D; Aventin A; Sborgia M; Martelli MF; Bohlander SK; Mecucci C
    Haematologica; 2006 Sep; 91(9):1248-51. PubMed ID: 16956826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.
    Caudell D; Zhang Z; Chung YJ; Aplan PD
    Cancer Res; 2007 Sep; 67(17):8022-31. PubMed ID: 17804713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.